# Evaluation of Myocardial Effects of MTP-131 for Reducing Reperfusion Injury in Patients With Acute Coronary Events

Study · id `cardio:ct-nct01572909` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01572909](<https://clinicaltrials.gov/study/NCT01572909>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01572909

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 300 participants.

## Technical summary

Registry record NCT01572909. Randomized; triple masking; primary purpose treatment. Start 2012-04 (registry gives no type); primary completion 2014-11 (actual). Results posted on 2020-06-11.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 300 participants (enrolled count; ClinicalTrials.gov record NCT01572909, source copy `cardio:ctgov-nct01572909-2020-06-11`, retrieved 2026-10-26)
- Start date: 2012-04 (registry gives no type) (ClinicalTrials.gov record NCT01572909, source copy `cardio:ctgov-nct01572909-2020-06-11`, retrieved 2026-10-26)
- Primary completion: 2014-11 (actual) (ClinicalTrials.gov record NCT01572909, source copy `cardio:ctgov-nct01572909-2020-06-11`, retrieved 2026-10-26)
- Completion: 2015-02 (actual) (ClinicalTrials.gov record NCT01572909, source copy `cardio:ctgov-nct01572909-2020-06-11`, retrieved 2026-10-26)
- Results first posted: 2020-06-11 (ClinicalTrials.gov record NCT01572909, source copy `cardio:ctgov-nct01572909-2020-06-11`, retrieved 2026-10-26)
- Countries: United States; Germany; Hungary; Poland (ClinicalTrials.gov record NCT01572909, source copy `cardio:ctgov-nct01572909-2020-06-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01572909-2020-06-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluation of Myocardial Effects of MTP-131 for Reducing Reperfusion Injury in Patients With Acute Coronary Events
- Acronym: EMBRACE
- Condition: Reperfusion Injury
- Condition: STEMI
- Intervention (Drug): Bendavia (MTP-131)
- Intervention (Drug): Placebo
- Lead sponsor: Stealth BioTherapeutics Inc.
- Lead sponsor class: INDUSTRY
- Collaborator: ICON Clinical Research
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Relation of Left Ventricular Mass and Infarct Size in Anterior Wall ST-Segment Elevation Acute Myocardial Infarction (from the EMBRACE STEMI Clinical Trial) (`cardio:pubmed-27392509`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: ac1c7ffcd6a62b614ccd161e45f3b5b6119661812ca1769a2d68414f19aa0d0a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
